Research consortium member, Dr. Sam Gandy, has developed a new approach for studying brain synapses that has begun to yield valuable information about the production of Amyloid-Beta oligomers, known to play a role in the onset of Alzheimer’s disease.

By better understanding how Abeta clumping is regulated, researchers can learn how to prevent, stop or slow Alzheimer’s pathology.

Dr. Gandy’s research, founded by Cure Alzheimer’s Fund, was published in the March 17th issue of the Journal of Neuroscience. Click here to read the article in its entirety.

Share: